{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:21:36Z","timestamp":1794565296473,"version":"4.9.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/md.0000000000000263","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T14:51:29Z","timestamp":1420728689000},"page":"e263","source":"Crossref","is-referenced-by-count":58,"title":["Beh\u00e7et's Disease Complicated with Thrombosis"],"prefix":"10.1097","volume":"93","author":[{"given":"Xiuhua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210309","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Behcets Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.","volume":"28","author":"Davatchi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-22-20210309","first-page":"1078","article-title":"International Study Group for Behcets Disease.","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"R3-22-20210309","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/qjmed\/hcl051","article-title":"How should we diagnose suspected deep-vein thrombosis","volume":"99","author":"Goodacre","year":"2006","journal-title":"QJM"},{"key":"R4-22-20210309","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12013-014-9826-6","article-title":"The value of CTPA for diagnosing acute pulmonary thromboembolism and the ensuing right ventricular dysfunction.","volume":"69","author":"Wang","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"R5-22-20210309","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart AssociationAmerican Stroke Association.","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"key":"R6-22-20210309","first-page":"59","article-title":"Diagnosis and treatment of inferior vena cava thrombosis.","volume":"10","author":"Asamov","year":"2010","journal-title":"Ross Akad Med Nauk"},{"key":"R7-22-20210309","first-page":"129","article-title":"Superior vena cava obstruction: diagnosis, management and outcome.","volume":"85","author":"Adegboye","year":"2008","journal-title":"East Afr Med J"},{"key":"R8-22-20210309","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MAJ.0b013e318272b0b0","article-title":"Intracardiac thrombus: diagnosis, complications and management.","volume":"345","author":"Egolum","year":"2013","journal-title":"Am J Med Sci"},{"key":"R9-22-20210309","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"R10-22-20210309","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Behcets disease: an update.","volume":"23","author":"Calamia","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R11-22-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.berh.2012.12.005","article-title":"Thrombosis in vasculitis.","volume":"27","author":"Gaffo","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R12-22-20210309","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10067-013-2205-7","article-title":"Major vascular involvement in Behcets disease: a retrospective study of 796 patients.","volume":"32","author":"Fei","year":"2013","journal-title":"Clin Rheumatol"},{"key":"R13-22-20210309","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-4632.2006.02832.x","article-title":"Vascular involvement in Behcets disease: a retrospective analysis of 2319 cases.","volume":"45","author":"Sarica-Kucukoglu","year":"2006","journal-title":"Int J Dermatol"},{"key":"R14-22-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740500255761","article-title":"Characteristics of vascular involvement in Behcets disease.","volume":"35","author":"Duzgun","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"R15-22-20210309","doi-asserted-by":"crossref","first-page":"e2011026","DOI":"10.4084\/mjhid.2011.026","article-title":"Behcets syndrome and thrombosis.","volume":"3","author":"Seyahi","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R16-22-20210309","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/BOR.0b013e32835ad3ca","article-title":"Thrombosis in vasculitis.","volume":"25","author":"Springer","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R18-22-20210309","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00415-010-5885-9","article-title":"Cerebral venous thrombosis in Behcets disease: a systematic review.","volume":"258","author":"Aguiar de Sousa","year":"2011","journal-title":"J Neurol"},{"key":"R19-22-20210309","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.24393","article-title":"Cerebral venous thrombosis in Behcets disease.","volume":"61","author":"Saadoun","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R20-22-20210309","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1378\/chest.118.2.479","article-title":"Intracardiac thrombus in Behcets disease: a systematic review.","volume":"118","author":"Mogulkoc","year":"2000","journal-title":"Chest"},{"key":"R21-22-20210309","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e3182428f49","article-title":"Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature.","volume":"91","author":"Geri","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"R22-22-20210309","first-page":"2404","article-title":"Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcets disease.","volume":"26","author":"Mader","year":"1999","journal-title":"J Rheumatol"},{"key":"R23-22-20210309","first-page":"215","article-title":"The evaluation of coagulation parameters and vessel involvement in Behcets disease. A clinical experience of Behcets disease: study of 152 cases.","volume":"51","author":"Harman","year":"2013","journal-title":"Acta Med Iran"},{"key":"R24-22-20210309","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s002680010282","article-title":"Comparison of coagulation parameters for healthy subjects and Behcet disease patients with and without vascular involvement.","volume":"24","author":"Sengul","year":"2000","journal-title":"World J Surg"},{"key":"R25-22-20210309","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2141.2004.05072.x","article-title":"Activated protein C levels in Behcets disease and risk of venous thrombosis.","volume":"126","author":"Navarro","year":"2004","journal-title":"Br J Haematol"},{"key":"R26-22-20210309","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00296-006-0214-4","article-title":"Decreased protein S activity is related to the disease activity of Behcets disease.","volume":"27","author":"Kwon","year":"2006","journal-title":"Rheumatol Int"},{"key":"R27-22-20210309","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2796.1996.396853000.x","article-title":"Impaired haemostatic kinetics and endothelial function in Behcets disease.","volume":"240","author":"Haznedaroglu","year":"1996","journal-title":"J Intern Med"},{"key":"R28-22-20210309","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","article-title":"Vascular endothelial function and oxidative stress mechanisms in patients with Behcets syndrome.","volume":"37","author":"Chambers","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R29-22-20210309","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07078.x","article-title":"Fibrinolytic inhibitor levels and polymorphisms in Behcet disease and their association with thrombosis.","volume":"141","author":"Ricart","year":"2008","journal-title":"Br J Haematol"},{"key":"R30-22-20210309","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1076029606293430","article-title":"Circulated activated platelets and increased platelet reactivity in patients with Behcets disease.","volume":"12","author":"Akar","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"R31-22-20210309","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.autrev.2012.11.001","article-title":"Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behcets disease: a systematic review and meta-analysis.","volume":"12","author":"Chamorro","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R32-22-20210309","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Behcet disease.","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:38:54Z","timestamp":1620959934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201412030-00022"}},"subtitle":["A Report of 93 Chinese Cases"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000263","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}